Global Non-invasive Cancer Diagnosis Market By Type (Clinical Chemistry, Immunochemistry/Immunoassay, and Molecular Diagnostics), By Application (Blood Cancer, Solid Tumors, Breast Cancer, and Lung Cancer), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 139321
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Non-invasive Cancer Diagnosis Market is estimated to be valued US$ XX.X million in 2019. The report on Non-invasive Cancer Diagnosis Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global non-invasive cancer diagnosis market is segmented on the basis of Type, Application, and geography.
In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.
Non-invasive Cancer Diagnosis Market Scope:
By type, the market is segmented into Clinical Chemistry, Immunochemistry/Immunoassay, and Molecular Diagnostics. By Application, the market is divided into Blood Cancer, Solid Tumors, Breast Cancer, and Lung Cancer.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Gen-Probe Inc., A&G Pharmaceutical, Affymetrix Inc., Digene Corporation, Quest Diagnostics Inc., BioView Inc., LabCorp, AVIVA Biosciences Corporation, and Precision Therapeutics.Key Market Segments
Type
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Application
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Key Market Players included in the report:
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Non-invasive Cancer Diagnosis Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Non-invasive Cancer Diagnosis Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Non-invasive Cancer Diagnosis Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Non-invasive Cancer Diagnosis Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Non-invasive Cancer Diagnosis Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Non-invasive Cancer Diagnosis Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Non-invasive Cancer Diagnosis sub-markets, depending on key regions (various vital states).
To analyze Non-invasive Cancer Diagnosis Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Non-invasive Cancer Diagnosis Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Non-invasive Cancer Diagnosis Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Non-invasive Cancer Diagnosis Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Non-invasive Cancer Diagnosis Market Overview
3.1. Non-invasive Cancer Diagnosis Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Non-invasive Cancer Diagnosis Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Non-invasive Cancer Diagnosis Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Clinical Chemistry4.4. Immunochemistry/Immunoassay
4.5. Molecular Diagnostics
5. Global Non-invasive Cancer Diagnosis Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Non-invasive Cancer Diagnosis Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Blood Cancer5.4. Solid Tumors
5.5. Breast Cancer
5.6. Lung Cancer
6. Global Non-invasive Cancer Diagnosis Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Non-invasive Cancer Diagnosis Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Non-invasive Cancer Diagnosis Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Non-invasive Cancer Diagnosis Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Non-invasive Cancer Diagnosis Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Non-invasive Cancer Diagnosis Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global Non-invasive Cancer Diagnosis Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Gen-Probe Inc.7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. A&G Pharmaceutical
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Affymetrix Inc.
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Digene Corporation
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Quest Diagnostics Inc.
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. BioView Inc.
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. LabCorp
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. AVIVA Biosciences Corporation
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Precision Therapeutics
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
